圧受容器反射 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "圧受容器反射" in Japanese language version.

refsWebsite

Global rank Japanese rank

7nih.gov

4^th place

24^th place

5doi.org

2^nd place

6^th place

2worldcat.org

5^th place

19^th place

doi.org

Bär, Karl-Jürgen (2015-06-24). “Cardiac Autonomic Dysfunction in Patients with Schizophrenia and Their Healthy Relatives – A Small Review”. Frontiers in Neurology (Frontiers Media SA) 6: 139. doi:10.3389/fneur.2015.00139. ISSN 1664-2295. PMC 4478389. PMID 26157417.
Fu, Shihui; Ping, Ping; Wang, Fengqi; Luo, Leiming (2018-01-12). “Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure”. Journal of Biological Engineering (Springer Nature) 12 (1): 2. doi:10.1186/s13036-017-0093-0. ISSN 1754-1611. PMC 5766980. PMID 29344085. "They are mainly produced by cardiovascular, brain and renal tissues in response to wall stretch and other causes. NPs provide natriuresis, diuresis, vasodilation, antiproliferation, antihypertrophy, antifibrosis and other cardiometabolic protection. NPs represent body’s own antihypertensive system, and provide compensatory protection to counterbalance vasoconstrictor-mitogenic-sodium retaining hormones, released by renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)."
Sleight, Peter; La Rovere, Maria Teresa; Mortara, Andrea; Pinna, Gianni; Maestri, Roberto; Leuzzi, Stefano; Bianchini, Beatrice; Tavazzi, Luigi et al. (1 January 1995). “Physiology and Pathophysiology of Heart Rate and Blood Pressure Variability in Humans: Is Power Spectral Analysis Largely An Index of Baroreflex Gain?”. Clinical Science 88 (1): 103–109. doi:10.1042/cs0880103. PMID 7677832.
Wallbach, M; Koziolek, MJ (9 November 2017). “Baroreceptors in the carotid and hypertension-systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure.”. Nephrology, Dialysis, Transplantation 33 (9): 1485–1493. doi:10.1093/ndt/gfx279. PMID 29136223.
Abraham, WT; Zile, MR; Weaver, FA; Butter, C; Ducharme, A; Halbach, M; Klug, D; Lovett, EG et al. (June 2015). “Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.”. JACC: Heart Failure 3 (6): 487–496. doi:10.1016/j.jchf.2015.02.006. PMID 25982108.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bär, Karl-Jürgen (2015-06-24). “Cardiac Autonomic Dysfunction in Patients with Schizophrenia and Their Healthy Relatives – A Small Review”. Frontiers in Neurology (Frontiers Media SA) 6: 139. doi:10.3389/fneur.2015.00139. ISSN 1664-2295. PMC 4478389. PMID 26157417.
Fu, Shihui; Ping, Ping; Wang, Fengqi; Luo, Leiming (2018-01-12). “Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure”. Journal of Biological Engineering (Springer Nature) 12 (1): 2. doi:10.1186/s13036-017-0093-0. ISSN 1754-1611. PMC 5766980. PMID 29344085. "They are mainly produced by cardiovascular, brain and renal tissues in response to wall stretch and other causes. NPs provide natriuresis, diuresis, vasodilation, antiproliferation, antihypertrophy, antifibrosis and other cardiometabolic protection. NPs represent body’s own antihypertensive system, and provide compensatory protection to counterbalance vasoconstrictor-mitogenic-sodium retaining hormones, released by renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)."
Sleight, Peter; La Rovere, Maria Teresa; Mortara, Andrea; Pinna, Gianni; Maestri, Roberto; Leuzzi, Stefano; Bianchini, Beatrice; Tavazzi, Luigi et al. (1 January 1995). “Physiology and Pathophysiology of Heart Rate and Blood Pressure Variability in Humans: Is Power Spectral Analysis Largely An Index of Baroreflex Gain?”. Clinical Science 88 (1): 103–109. doi:10.1042/cs0880103. PMID 7677832.
Wallbach, M; Koziolek, MJ (9 November 2017). “Baroreceptors in the carotid and hypertension-systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure.”. Nephrology, Dialysis, Transplantation 33 (9): 1485–1493. doi:10.1093/ndt/gfx279. PMID 29136223.
Abraham, WT; Zile, MR; Weaver, FA; Butter, C; Ducharme, A; Halbach, M; Klug, D; Lovett, EG et al. (June 2015). “Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.”. JACC: Heart Failure 3 (6): 487–496. doi:10.1016/j.jchf.2015.02.006. PMID 25982108.

ncbi.nlm.nih.gov

Bär, Karl-Jürgen (2015-06-24). “Cardiac Autonomic Dysfunction in Patients with Schizophrenia and Their Healthy Relatives – A Small Review”. Frontiers in Neurology (Frontiers Media SA) 6: 139. doi:10.3389/fneur.2015.00139. ISSN 1664-2295. PMC 4478389. PMID 26157417.
Fu, Shihui; Ping, Ping; Wang, Fengqi; Luo, Leiming (2018-01-12). “Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure”. Journal of Biological Engineering (Springer Nature) 12 (1): 2. doi:10.1186/s13036-017-0093-0. ISSN 1754-1611. PMC 5766980. PMID 29344085. "They are mainly produced by cardiovascular, brain and renal tissues in response to wall stretch and other causes. NPs provide natriuresis, diuresis, vasodilation, antiproliferation, antihypertrophy, antifibrosis and other cardiometabolic protection. NPs represent body’s own antihypertensive system, and provide compensatory protection to counterbalance vasoconstrictor-mitogenic-sodium retaining hormones, released by renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)."

worldcat.org

search.worldcat.org

Bär, Karl-Jürgen (2015-06-24). “Cardiac Autonomic Dysfunction in Patients with Schizophrenia and Their Healthy Relatives – A Small Review”. Frontiers in Neurology (Frontiers Media SA) 6: 139. doi:10.3389/fneur.2015.00139. ISSN 1664-2295. PMC 4478389. PMID 26157417.
Fu, Shihui; Ping, Ping; Wang, Fengqi; Luo, Leiming (2018-01-12). “Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure”. Journal of Biological Engineering (Springer Nature) 12 (1): 2. doi:10.1186/s13036-017-0093-0. ISSN 1754-1611. PMC 5766980. PMID 29344085. "They are mainly produced by cardiovascular, brain and renal tissues in response to wall stretch and other causes. NPs provide natriuresis, diuresis, vasodilation, antiproliferation, antihypertrophy, antifibrosis and other cardiometabolic protection. NPs represent body’s own antihypertensive system, and provide compensatory protection to counterbalance vasoconstrictor-mitogenic-sodium retaining hormones, released by renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)."